Fulcrum Therapeutics
FULC
FULC
128 hedge funds and large institutions have $496M invested in Fulcrum Therapeutics in 2025 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 40 increasing their positions, 43 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
7% less repeat investments, than reductions
Existing positions increased: 40 | Existing positions reduced: 43
1.34% less ownership
Funds ownership: 100.78% → 99.44% (-1.3%)
Holders
128
Holding in Top 10
2
Calls
$1.64M
Puts
$125K
Top Buyers
| 1 | +$7.21M | |
| 2 | +$6.23M | |
| 3 | +$4.98M | |
| 4 |
BFM
Boothbay Fund Management
New York
|
+$3.89M |
| 5 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$2.77M |
Top Sellers
| 1 | -$15.6M | |
| 2 | -$6.18M | |
| 3 | -$4.86M | |
| 4 |
Goldman Sachs
New York
|
-$4.03M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$3.43M |
